IceCure Medical Ltd (ICCM) vs Mustang Bio, Inc. (MBIO)

A side-by-side comparison of IceCure Medical Ltd and Mustang Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ICCM vs MBIO

growth of $100 · dividends reinvested · last 5y
ICCM -99.5% (-65.8%/yr)MBIO -100.0% (-81.6%/yr)ICCM compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020222023202420252026$0$0
ICCM MBIO

ICCM vs MBIO: by the numbers

  • •MBIO is the larger company ($4M vs $3M market cap).
  • •Both run net losses; MBIO's is the smaller (0.00% vs -427.67% net margin).

Metrics side by side

Valuation

MetricICCMMBIO
P/S ratio0.85N/A
P/B ratio0.280.47

Profitability

MetricICCMMBIO
Gross margin36.10%0.00%
Operating margin-446.70%0.00%
Net margin-427.67%0.00%
ROE-141.90%-40.20%
ROIC-184.27%-45.77%

Growth (annualized)

MetricICCMMBIO
Revenue CAGR (5Y)-0.69%N/A
Total return CAGR (5Y)-63.05%-80.80%

Frequently asked

How have ICCM and MBIO total returns compared?
Over the past 5 years, ICCM delivered -63.05% and MBIO delivered -80.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.